Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II

Cancer Chemotherapy and Pharmacology

Volumn 9, Issue 3, 1982, Pages 140-147

  Calvert, A H ^a,b   Harland, S J ^a,b   Newell, D R ^a,b   Siddik, Z H ^a,b   Jones, A C ^a,b   McElwain, T J ^a,b   Raju, S ^a,b   Wiltshaw, E ^a,b   Smith, I E ^a,b   Baker, J M ^a,b   Peckham, M J ^a,b   Harrap, K R ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; EDETATE CHROMIUM CR 51; NEW DRUG;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG TOXICITY; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; PHARMACOKINETICS; PHARMACOLOGY; THERAPY; VOMITING;

ADULT; AGED; ANEMIA; BONE MARROW; CARBOPLATIN; FEMALE; HEARING; HUMANS; KIDNEY; LEUKOPENIA; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; ORGANOPLATINUM COMPOUNDS; PARESTHESIA; THROMBOCYTOPENIA; VOMITING;

EID: 0020402899     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00257742     Document Type: Article

References (24)

1. Treatment of advanced ovarian cancer with cis-dichlorodiammineplatinum (II): Poor risk patients with intensive prior therapy
2. Parameters of nephrotoxicity in relation to the administration of cis-DPD
3. The chemotherapy of urologic cancer
4. Glomerular filtration rate measurement in man by the single injection methods using Cr51 EDTA
5. Antitumour, toxic and biochemical properties of cisplatin and eight other platinum complexes
6. High-dose cis-platinum diamminedichloride
7. cis-Diamminedichloride platinum II in the treatment of advanced bladder cancer
8. Diamminodichloroplatinum in the chemotherapy of testicular tumors
9. The role of cisplatin in the treatment of recurrent head and neck cancer
10. Comparison of methods of evaluating nephrotoxicity of cisplatinum
11. Clinical, pharmacological and toxicological studies of cis-diamminedichloroplatinum (II) by continuous infusion
12. Treatment of advanced bladder cancer with cis-diamminedichloroplatinum (II) (NSC 119875): A pilot study
13. Treatment of genitourinary tumors with cis-dichlorodiammineplatinum (II): Experience in 250 patients
14. Cisplatin (cis-diamminedichloroplatinum II)
15. Ototoxicity in patients receiving cisplatin: Importance of dose and method of drug administration
16. Toxic effects of cis-dichlorodiammineplatinum (II) in man
17. Selection of potential second generation platinum compounds
18. cis-Platinum: A new anticancer agent
19. cis-Platinum(II)diamminedichloride: Clinical experience of the Royal Marsden Hospital and Institute of Cancer Research
20. Phase II study of cis-dichloro-diammineplatinum (I) (NSC 119875) in advanced adenocarcinoma of the ovary
21. Cisplatin treatment of cutaneous T-cell lymphoma
22. cis-Dichlorodiammineplatinum (II) in advanced bladder cancer
23. cis-Dichlorodiammineplatinum (II) for the treatment of advanced ovarian cancer